Study details
Enrolling now
Phase I Trial of Fractionated Stereotactic Radiation Therapy
Albert Einstein College of Medicine
NCT IDNCT03726359ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
43
Study length
about 9.4 years
Ages
18+
Locations
1 site in NY
What this study is about
This trial is testing whether a treatment called Fractionated Stereotactic Radiation Therapy (FSRT) can be safely used to treat brain metastases. The goal of this Phase 1 trial is to determine the maximum tolerated dose and assess the safety of FSRT in adults with brain metastases.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Fractionated Stereotactic Radiation Therapy (FSRT)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Maximum Tolerated Dose (MTD)
Procedures
radiation